{"content":"<li class=\"n-box-item date-title\" data-end=\"1497499199\" data-start=\"1497412800\" data-txt=\"Monday, December 23, 2019\">Wednesday, June 14, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3273591\" data-ts=\"1497481349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HGV\" target=\"_blank\">HGV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273591-hilton-grand-vacations-offers-9_65m-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hilton Grand Vacations offers 9.65M secondary</a></h4><ul>   <li>Hilton Grand Vacations (<a href=\"http://seekingalpha.com/symbol/HGV\" target=\"_blank\">HGV</a> <font color='red'>-1.9%</font>) has announced a secondary offering of 9.65M shares of common stock.</li>    <li>The company's not selling stock into the offering and won't receive proceeds; neither are any officers or directors.</li>    <li>J.P. Morgan is serving as underwriter.</li>    <li>Shares are flat after hours; they're <font color='green'>up 36.2%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273591\" data-linked=\"Hilton Grand Vacations offers 9.65M secondary\" data-tweet=\"$HGV - Hilton Grand Vacations offers 9.65M secondary https://seekingalpha.com/news/3273591-hilton-grand-vacations-offers-9_65m-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3273591-hilton-grand-vacations-offers-9_65m-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273590\" data-ts=\"1497479336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXS\" target=\"_blank\">AVXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273590-avexis-says-fda-supports-proposed-analytical-methods-for-drug-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AveXis says FDA supports proposed analytical methods for drug candidate</a></h4><ul><li>AveXis (NASDAQ:<a href='https://seekingalpha.com/symbol/AVXS' title='AveXis'>AVXS</a>) <font color='green'>+6.1%</font>&nbsp;AH after announcing <a href=\"https://seekingalpha.com/pr/16862309-avexis-announces-alignment-fda-gmp-commercial-manufacturing-process-avxsminus-101\" target=\"_blank\">alignment with the FDA</a> on its manufacturing process, analytical methods and comparability  protocol for its AVXS-101 gene therapy candidate.</li><li>AVXS-101 is a  one-time treatment for spinal muscular atrophy Type 1, a genetic muscular disease leading to  reduced muscle movement.</li><li>The company expects to initiate a pivotal study trial of AVXS-101 in SMA Type 1 in the U.S. and a Phase 1/2a trial of AVXS-101 in SMA Type 2 in the U.S. later during Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273590\" data-linked=\"AveXis says FDA supports proposed analytical methods for drug candidate\" data-tweet=\"$AVXS - AveXis says FDA supports proposed analytical methods for drug candidate https://seekingalpha.com/news/3273590-avexis-says-fda-supports-proposed-analytical-methods-for-drug-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3273590-avexis-says-fda-supports-proposed-analytical-methods-for-drug-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273582\" data-ts=\"1497476294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273582-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a> <font color='green'>+9.7%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='green'>+5.3%</font>. <a href='https://seekingalpha.com/symbol/JBL' title='Jabil Inc.'>JBL</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='green'>+3.0%</font>. <a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a> <font color='green'>+2.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='red'>-7.1%</font>. <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='red'>-6.1%</font>. <a href='https://seekingalpha.com/symbol/LNTH' title='Lantheus Holdings'>LNTH</a> <font color='red'>-5.2%</font>. OAKS <font color='red'>-5.1%</font>. BBG <font color='red'>-2.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273582\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$LAKE $ADXS $JBL - After Hours Gainers / Losers https://seekingalpha.com/news/3273582-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3273582-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273572\" data-ts=\"1497473803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROX\" target=\"_blank\">ROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273572-castle-brands-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Castle Brands EPS in-line, beats on revenue</a></h4><ul><li>Castle Brands (NYSEMKT:<a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a>): Q4 EPS of $0.00 in-line.</li><li>Revenue of $22.58M (+13.1% Y/Y) <font color='green'>beats by $1.12M</font>.</li><li>Shares <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/pr/16862409-castle-brands-announces-fourth-quarter-fiscal-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273572\" data-linked=\"Castle Brands EPS in-line, beats on revenue\" data-tweet=\"$ROX - Castle Brands EPS in-line, beats on revenue https://seekingalpha.com/news/3273572-castle-brands-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3273572-castle-brands-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273571\" data-ts=\"1497473648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPS\" target=\"_blank\">APPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273571-digital-turbine-dips-on-worse-expected-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Turbine dips on worse-than-expected Q4 loss</a></h4><ul>   <li>Digital Turbine (<a href=\"http://seekingalpha.com/symbol/APPS\" target=\"_blank\">APPS</a> <font color='red'>-2%</font>) has turned still lower after hours, <font color='red'>-2.1%</font>, after posting <a href=\"https://seekingalpha.com/news/3273554-digital-turbine-misses-0_02-beats-revenue\" target=\"_blank\">Q4 earnings</a> with a wider-than-expected loss on slightly lower revenues.</li>    <li>Revenue beat expectations and came in slightly higher than even the seasonally strong third quarter. But net loss on a GAAP basis was $6.9M and EBITDA came in at -$0.7M (vs. -$2M expected).</li>    <li>Gross margin rose to 28% from Q3's 24% as the mix shifts to higher-margin operators and OEMs business.</li>    <li>It's guiding to Q1 revenue of about $25M (vs. $24.2M expected) and \"further sequential improvement in non-GAAP adjusted EBITDA.\" It also says it expected that EBITDA measure to be positive for fiscal 2018.</li>    <li><a href=\"https://seekingalpha.com/pr/16862356-digital-turbine-reports-fourth-quarter-fiscal-full-year-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3273571\" data-linked=\"Digital Turbine dips on worse-than-expected Q4 loss\" data-tweet=\"$APPS - Digital Turbine dips on worse-than-expected Q4 loss https://seekingalpha.com/news/3273571-digital-turbine-dips-on-worse-expected-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3273571-digital-turbine-dips-on-worse-expected-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273570\" data-ts=\"1497473492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNTH\" target=\"_blank\">LNTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273570-lantheus-readies-3m-share-offering-existing-stockholders-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lantheus readies 3M-share offering by existing stockholders; shares down 5% after hours</a></h4><ul><li>Lantheus Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LNTH' title='Lantheus Holdings'>LNTH</a>) eases&nbsp;<font color='red'>5%</font>&nbsp;after hours on light volume after <a href=\"https://seekingalpha.com/pr/16862399-lantheus-holdings-inc-announces-public-secondary-offering-selling-stockholders-3000-000\" target=\"_blank\">announcing </a>an offering of 3M common shares by existing stockholders. The company will receive no proceeds for the sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273570\" data-linked=\"Lantheus readies 3M-share offering by existing stockholders; shares down 5% after hours\" data-tweet=\"$LNTH - Lantheus readies 3M-share offering by existing stockholders; shares down 5% after hours https://seekingalpha.com/news/3273570-lantheus-readies-3m-share-offering-existing-stockholders-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3273570-lantheus-readies-3m-share-offering-existing-stockholders-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273562\" data-ts=\"1497472365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCFT\" target=\"_blank\">HCFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273562-five-oaks-is-latest-mortgage-reit-to-raise-capital-sharesminus-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Oaks is latest mortgage REIT to raise capital; shares -1.5%</a></h4><ul><li>The company<a href=\"https://seekingalpha.com/pr/16862368-five-oaks-investment-corp-announces-public-offering-additional-shares-common-stock\" target=\"_blank\"> is selling 4M shares</a>, with underwriter greenshoe of 600K shares.</li><li>March 31 book value per share was $6.14. Today's close was a discount to that at $5.32.</li><li>OAKS&nbsp;<font color='red'>-1.5%</font>&nbsp;after hours to $5.24.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273562\" data-linked=\"Five Oaks is latest mortgage REIT to raise capital; shares -1.5%\" data-tweet=\"$HCFT - Five Oaks is latest mortgage REIT to raise capital; shares -1.5% https://seekingalpha.com/news/3273562-five-oaks-is-latest-mortgage-reit-to-raise-capital-sharesminus-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3273562-five-oaks-is-latest-mortgage-reit-to-raise-capital-sharesminus-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273561\" data-ts=\"1497472159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMMT\" target=\"_blank\">SMMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273561-summit-therapeutics-fiscal-q1-top-line-up-29-cf-ops-down-29_4-first-data-readout-from-mid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summit Therapeutics fiscal Q1 top line up 29%; CF Ops down 29.4%; first data readout from mid-stage study of DMD candidate ezutromid Q1 2018</a></h4><ul><li>Summit Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a>) <a href=\"https://seekingalpha.com/pr/16861332-summit-therapeutics-reports-financial-results-first-quarter-ended-30-april-2017-operational\" target=\"_blank\">fiscal Q1 results</a> ($M): Revenue: 2.2 (+29.4%); Net Loss: (6.2) (-29.4%); CF Ops: (10.3) (-29.4%).</li><li>Completed enrollment in Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02858362?term=phaseout+DMD&amp;rank=1\" target=\"_blank\">PhaseOut DMD</a> study of ezutromid in May. Week 24 data readout expected in Q1 2018.</li><li>Phase 3 studies of ridinilazole should commence in H1 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273561\" data-linked=\"Summit Therapeutics fiscal Q1 top line up 29%; CF Ops down 29.4%; first data readout from mid-stage study of DMD candidate ezutromid Q1 2018\" data-tweet=\"$SMMT - Summit Therapeutics fiscal Q1 top line up 29%; CF Ops down 29.4%; first data readout from mid-stage study of DMD candidate ezutromid Q1 2018 https://seekingalpha.com/news/3273561-summit-therapeutics-fiscal-q1-top-line-up-29-cf-ops-down-29_4-first-data-readout-from-mid?source=tweet\" data-url=\"https://seekingalpha.com/news/3273561-summit-therapeutics-fiscal-q1-top-line-up-29-cf-ops-down-29_4-first-data-readout-from-mid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273558\" data-ts=\"1497471819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBL\" target=\"_blank\">JBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273558-jabil-beats-estimates-guidance-strong-shares-up-over-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jabil beats estimates, guidance strong; shares up over 5%</a></h4><ul><li>        Jabil (NYSE:<a href='https://seekingalpha.com/symbol/JBL' title='Jabil Inc.'>JBL</a>) Q3 report beat EPS and revenue estimates. Core operating income was $113.8M and Jabil ended quarter with $743.9M in cash and equivalents. &nbsp;</li><li>        Q4 guidance includes $4.7B to $5.1B in revenue, compared to $4.79B consensus, and $0.50 to $0.74 EPS, which consensus puts at $0.62.</li><li>               Segment Q4 forecasts: Diversified Manufacturing Services expected to remain growth segment with 26% sales increase on the prior year&rsquo;s quarter; Electronics Manufacturing Services expecting a more modest 2% improvement.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16862324-jabil-posts-third-quarter-results\" target=\"_blank\">Press release</a>&nbsp;</li><li>Jabil shares are up 5.29% aftermarket. &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3273558\" data-linked=\"Jabil beats estimates, guidance strong; shares up over 5%\" data-tweet=\"$JBL - Jabil beats estimates, guidance strong; shares up over 5% https://seekingalpha.com/news/3273558-jabil-beats-estimates-guidance-strong-shares-up-over-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3273558-jabil-beats-estimates-guidance-strong-shares-up-over-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273548\" data-ts=\"1497471119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACB\" target=\"_blank\">PACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273548-pacific-bio-readies-equity-offering-shares-down-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Bio readies equity offering; shares down 9% after hours</a></h4><ul><li>Pacific Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a>) slips&nbsp;<font color='red'>9%</font>&nbsp;after hours on modest volume on the heels of its <a href=\"https://seekingalpha.com/pr/16862322-pacific-biosciences-california-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcement</a> of a public offering of common stock. Price, volume and terms have yet to be released.</li><li>Net proceeds will fund capex, working capital and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273548\" data-linked=\"Pacific Bio readies equity offering; shares down 9% after hours\" data-tweet=\"$PACB - Pacific Bio readies equity offering; shares down 9% after hours https://seekingalpha.com/news/3273548-pacific-bio-readies-equity-offering-shares-down-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3273548-pacific-bio-readies-equity-offering-shares-down-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273545\" data-ts=\"1497470771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMP\" target=\"_blank\">ADMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273545-adamis-showing-volatility-ahead-of-fda-decision-on-generic-epipen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adamis showing volatility ahead of FDA decision on generic EpiPen</a></h4><ul><li>Thinly traded micro cap Adamis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a>) had an up-and-down day ahead of tomorrow's expected FDA decision on its generic version of Mylan's emergency allergy med EpiPen (epinephrine injection).</li><li>Shares were down early, clawed back into the green, but then could not hold on to the gain. Shares ended the session up a fraction on lower-than-normal volume.</li><li>According to Bloomberg, short interest has dropped to ~5% of the float versus 12% in March.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271320-buying-picks-adamis-pharma-ahead-fda-decision-generic-epipen\" target=\"_blank\">Buying picks up in Adamis Pharma ahead of FDA decision on generic EpiPen</a> (June 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273545\" data-linked=\"Adamis showing volatility ahead of FDA decision on generic EpiPen\" data-tweet=\"$ADMP - Adamis showing volatility ahead of FDA decision on generic EpiPen https://seekingalpha.com/news/3273545-adamis-showing-volatility-ahead-of-fda-decision-on-generic-epipen?source=tweet\" data-url=\"https://seekingalpha.com/news/3273545-adamis-showing-volatility-ahead-of-fda-decision-on-generic-epipen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273542\" data-ts=\"1497470720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBL\" target=\"_blank\">JBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273542-jabil-circuit-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jabil Circuit beats by $0.02, beats on revenue</a></h4><ul><li>Jabil Circuit (NYSE:<a href='https://seekingalpha.com/symbol/JBL' title='Jabil Inc.'>JBL</a>): Q3 EPS of $0.31 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $4.49B (+4.2% Y/Y) <font color='green'>beats by $90M</font>.</li><li>Shares <font color='green'>+4%</font>.</li><li><a href='https://seekingalpha.com/pr/16862324-jabil-posts-third-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273542\" data-linked=\"Jabil Circuit beats by $0.02, beats on revenue\" data-tweet=\"$JBL - Jabil Circuit beats by $0.02, beats on revenue https://seekingalpha.com/news/3273542-jabil-circuit-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3273542-jabil-circuit-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273541\" data-ts=\"1497470666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAKE\" target=\"_blank\">LAKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273541-lakeland-industries-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lakeland Industries beats by $0.07, beats on revenue</a></h4><ul><li>Lakeland Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a>): Q1 EPS of $0.23 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $23M (+12.9% Y/Y) <font color='green'>beats by $1.03M</font>.</li><li>Shares <font color='green'>+1.69%</font>.</li><li><a href='https://seekingalpha.com/pr/16862316-lakeland-industries-inc-reports-strong-growth-revenues-profits-free-cash-flow-fiscal-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273541\" data-linked=\"Lakeland Industries beats by $0.07, beats on revenue\" data-tweet=\"$LAKE - Lakeland Industries beats by $0.07, beats on revenue https://seekingalpha.com/news/3273541-lakeland-industries-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3273541-lakeland-industries-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273536\" data-ts=\"1497470386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEG\" target=\"_blank\">KEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273536-key-energy-sells-frac-stack-and-well-testing-assets-for-23_7m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Key Energy sells frac stack and well testing assets for $23.7M</a></h4><ul>     <li>Key Energy Services (<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a> <font color='red'>-3.2%</font>) earlier announced the <a href=\"https://seekingalpha.com/pr/16860953-key-energy-services-announces-sale-frac-stack-well-testing-assets\" target=\"_blank\">sale of its frac stack and well-testing assets</a> as part of its strategy to focus on production services.</li>     <li>KEG sold the equipment to Covenant Testing Technologies for $23.7M in cash and stock.</li>     <li>KEG says the assets contributed 16% of Fishing &amp; Rental Services segment revenue in Q1.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273536\" data-linked=\"Key Energy sells frac stack and well testing assets for $23.7M\" data-tweet=\"$KEG - Key Energy sells frac stack and well testing assets for $23.7M https://seekingalpha.com/news/3273536-key-energy-sells-frac-stack-and-well-testing-assets-for-23_7m?source=tweet\" data-url=\"https://seekingalpha.com/news/3273536-key-energy-sells-frac-stack-and-well-testing-assets-for-23_7m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273533\" data-ts=\"1497469444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273533-gold-miners-sell-off-spot-price-falls-following-fed-rate-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold miners sell off as spot price falls following Fed rate hike</a></h4><ul><li>Gold miners post broad losses as spot gold prices drop after the Fed forged ahead with an interest rate increase and additional plans to tighten monetary policy; gold futures now <font color='red'>-0.6%</font> to $1,260.40/oz.</li><li>SPDR Gold Shares ETF (<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> <font color='red'>-0.6%</font>) retreats back towards yesterday's lows of the week near the $120 level.</li><li>Among the bigger precious metal names: ABX <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='red'>-3.1%</font>, <a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='red'>-2.2%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='red'>-4.4%</font>, <a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a> <font color='red'>-3.1%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-3%</font>, <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-3.3%</font>, <a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color='red'>-2.2%</font>, <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='red'>-7%</font>.</li><li>Bloomberg Intelligence wrote earlier this week that if the trend of the current rate tightening cycle is sustained, gold should bottom within a few days of  today&rsquo;s FOMC meeting,&nbsp;if history is a guide.</li><li>Source:&nbsp;Bloomberg First Word</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/SIVR' title='Aberd Std Silvr Shs'>SIVR</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares UltraShort Silver ETF'>ZSL</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/SLVO' title='Credit Suisse Silver Shares Covered Call ETN'>SLVO</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/DBS' title='Invesco DB Silver ETF'>DBS</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a>, <a href='https://seekingalpha.com/symbol/USV' title='UBS ETRACS CMCI Silver Total Return ETN'>USV</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/SHNY' title='Direxion Daily Silver Miners Index Bull 2x Shares ETF'>SHNY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273533\" data-linked=\"Gold miners sell off as spot price falls following Fed rate hike\" data-tweet=\"$GOLD $GLD $GOLD - Gold miners sell off as spot price falls following Fed rate hike https://seekingalpha.com/news/3273533-gold-miners-sell-off-spot-price-falls-following-fed-rate-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3273533-gold-miners-sell-off-spot-price-falls-following-fed-rate-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273531\" data-ts=\"1497469386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273531-ekso-up-48-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso up 48% on heavy volume</a></h4><ul><li>Thinly traded nano cap Ekso Bionics Holdings (<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+47.7%</font>) breaks out of a brief consolidation on a healthy 16x surge in volume. Buying picked up about a week ago after it announced that it completed developing a lightweight flexible-load exoskeleton called Artemis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271601-ekso-hold-premarket-gain-shares-10-percent\" target=\"_blank\">Ekso can't hold on to premarket gain, shares off 10%</a> (June 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273531\" data-linked=\"Ekso up 48% on heavy volume\" data-tweet=\"$EKSO - Ekso up 48% on heavy volume https://seekingalpha.com/news/3273531-ekso-up-48-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3273531-ekso-up-48-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273527\" data-ts=\"1497468159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273527-tech-energy-lead-averages-lower-post-fed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech, energy lead averages lower post-Fed</a></h4><ul><li>Stocks have moved into the red since the FOMC hiked rates 25 basis points at 2 PM ET. The policy statement, economic forecasts, and <a href=\"https://seekingalpha.com/news/3273517-yellen-press-conference-live-coverage\" target=\"_blank\">Yellen press conference</a> show the Fed as being mostly dismissive of any recent soft economic or inflation reads. Another rate hike this year - perhaps in the early fall - seems to be in the works.</li><li>The Nasdaq is&nbsp;<font color='red'>down 1%</font>, and S&amp;P 500&nbsp;<font color='red'>0.4%</font>. The energy sector is&nbsp;<font color='red'>off 2%</font>&nbsp;as oil crumbles to a new 2017 low.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273527\" data-linked=\"Tech, energy lead averages lower post-Fed\" data-tweet=\"Tech, energy lead averages lower post-Fed https://seekingalpha.com/news/3273527-tech-energy-lead-averages-lower-post-fed?source=tweet\" data-url=\"https://seekingalpha.com/news/3273527-tech-energy-lead-averages-lower-post-fed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273525\" data-ts=\"1497467005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CC\" target=\"_blank\">CC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273525-chemours-made-toxin-found-in-north-carolina-water-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chemours-made toxin found in North Carolina water supply</a></h4><ul>     <li>Chemours (<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a> <font color='red'>-2.6%</font>) plunges following a report that it <a href=\"http://wunc.org/post/toxins-found-cape-fear-water-supply#stream/0\" target=\"_blank\">released toxic chemicals</a> that ended up in the Cape Fear drinking water supply in North Carolina.</li><li>Researchers last month found a contaminant called GenX, made at the company's Fayetteville Works facility as a replacement for a hazardous  ingredient in Teflon, in the water supply, according to a report from WUNC radio.</li><li>GenX is not regulated, since it is a relatively new compound and little data is available describing its health effects.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273525\" data-linked=\"Chemours-made toxin found in North Carolina water supply\" data-tweet=\"$CC - Chemours-made toxin found in North Carolina water supply https://seekingalpha.com/news/3273525-chemours-made-toxin-found-in-north-carolina-water-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3273525-chemours-made-toxin-found-in-north-carolina-water-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273523\" data-ts=\"1497466897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273523-tv-upfronts-nbc-fox-abc-making-progress\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TV upfronts: NBC, Fox, ABC making progress</a></h4><ul>   <li>It's still early days for TV's upfront sales season, but following a <a href=\"https://seekingalpha.com/news/3272740-variety-cbs-cablers-start-early-upfront-ad-sales\" target=\"_blank\">jump from CBS and cable nets</a>, NBCUniversal (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-0.2%</font>), Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-2.1%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-2%</font>) and ABC (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-0.6%</font>) are <a href=\"http://variety.com/2017/tv/news/2017-upfront-tv-advertising-nbcuniversal-fox-abc-1202466022/\" target=\"_blank\">making progress</a>, <i>Variety</i> reports.</li>    <li>The difference between what networks want (in terms of CPM) and what they get is still in flux. But NBC looks more like the initial pushes from CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-1.9%</font>), in seeking low double-digit increases for prime-time inventory, while Fox and ABC are aiming high single digits.</li>    <li>&ldquo;Everyone came out high&rdquo; with rate increases, one top media buyer tells <i>Variety.</i> &ldquo;There&rsquo;s not a buyer who will stand for that.&rdquo;</li>    <li>Fox is seeing early interest in FX inventory as well as a suite of new ad products it's begun rolling out.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273523\" data-linked=\"TV upfronts: NBC, Fox, ABC making progress\" data-tweet=\"$FOX $FOX $FOXA - TV upfronts: NBC, Fox, ABC making progress https://seekingalpha.com/news/3273523-tv-upfronts-nbc-fox-abc-making-progress?source=tweet\" data-url=\"https://seekingalpha.com/news/3273523-tv-upfronts-nbc-fox-abc-making-progress\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273524\" data-ts=\"1497466820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273524-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/NAME' title='Rightside Group, Ltd.'>NAME</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SMI' title='Semiconductor Manufacturing International Corporation'>SMI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/MIXT' title='MiX Telematics Limited'>MIXT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ZDGE' title='Zedge, Inc.'>ZDGE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273524\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$MTBC $NAME $SMI - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3273524-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3273524-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273521\" data-ts=\"1497466816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273521-avon-spikes-on-talk-of-ceo-exit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon spikes on talk of CEO exit</a></h4><ul><li>Shares of Avon Products (<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='green'>+3.4%</font>) perk up after Dow Jones reports that CEO Sheri McCoy is expected to step down from her position.</li><li>McCoy has been the CEO at Avon since 2012.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273521\" data-linked=\"Avon spikes on talk of CEO exit\" data-tweet=\"$AVP - Avon spikes on talk of CEO exit https://seekingalpha.com/news/3273521-avon-spikes-on-talk-of-ceo-exit?source=tweet\" data-url=\"https://seekingalpha.com/news/3273521-avon-spikes-on-talk-of-ceo-exit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273520\" data-ts=\"1497466552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVNA\" target=\"_blank\">CVNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273520-volatility-high-on-carvana-battle-lines-drawn\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatility high on Carvana as battle lines drawn</a></h4><ul><li>Carvana (NYSE:<a href='https://seekingalpha.com/symbol/CVNA' title='Carvana Co.'>CVNA</a>) is&nbsp;<font color='green'>up 9.20%</font>&nbsp;to carve out a post-IPO high of $16.84.</li><li>In just five trading sessions, share have jumped 30% as sentiment over the highly-shorted (29% short interest to float) stock has swung positive.</li><li>Some analysts think the market overreacted to the decline in used car prices. Carvana slid to as low as $8.14 after the IPO was priced at $15.</li><li>While investment firms (mostly underwriters) <a href=\"https://seekingalpha.com/news/3269282-analysts-launch-favorable-coverage-carvana\" target=\"_blank\">launched</a> very favorable coverage on Carvana last month, <a href=\"https://seekingalpha.com/symbol/CVNA/latest\" target=\"_blank\">SA contributors </a>aren't so sure about the stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273520\" data-linked=\"Volatility high on Carvana as battle lines drawn\" data-tweet=\"$CVNA - Volatility high on Carvana as battle lines drawn https://seekingalpha.com/news/3273520-volatility-high-on-carvana-battle-lines-drawn?source=tweet\" data-url=\"https://seekingalpha.com/news/3273520-volatility-high-on-carvana-battle-lines-drawn\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273519\" data-ts=\"1497466421\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDP\" target=\"_blank\">GDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273519-goodrich-petroleum-reveals-strong-results-from-louisiana-gas-well\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodrich Petroleum reveals strong results from Louisiana gas well</a></h4><ul>     <li>Goodrich Petroleum (<a href='https://seekingalpha.com/symbol/GDP' title='Goodrich Petroleum Corp.'>GDP</a> <font color='green'>+1.5%</font>) is higher even as most other energy company stocks swoon, after reporting <a href=\"https://seekingalpha.com/pr/16861227-goodrich-petroleum-announces-haynesville-shale-well-result-operational-update-increased\" target=\"_blank\">better than expected results</a> from a Haynesville shale gas well in Louisiana.</li>     <li>GDP says its Wurtsbaugh 25&amp;24 No. 1 well, which was fracked with ~4K lbs. of proppant per  ft. on a 9K-ft. lateral, achieved a 24-hour peak rate of 31M cf/day.</li><li>The company expects to spud its next well, the Franks 25&amp;24 No. 1, in mid-July with a planned 10K-ft. lateral, and plans to drill and complete two additional long lateral wells  later in the year.</li><li>GDP also says its recent acquisition of a 600-acre lease adjacent to its  existing acreage in Red River Parish, La., will allow it to expand activity with five 10K-ft. laterals and one  additional 4,600-ft. lateral.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273519\" data-linked=\"Goodrich Petroleum reveals strong results from Louisiana gas well\" data-tweet=\"$GDP - Goodrich Petroleum reveals strong results from Louisiana gas well https://seekingalpha.com/news/3273519-goodrich-petroleum-reveals-strong-results-from-louisiana-gas-well?source=tweet\" data-url=\"https://seekingalpha.com/news/3273519-goodrich-petroleum-reveals-strong-results-from-louisiana-gas-well\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273513\" data-ts=\"1497465026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273513-nokias-fast-routers-pursue-web-scale-customer-base\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia&#39;s fast routers pursue Web-scale customer base</a></h4><ul>   <li>Nokia (NYSE:<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a>) is taking aim at rivals Cisco (<a href=\"http://seekingalpha.com/symbol/CSCO\" target=\"_blank\">CSCO</a> <font color='red'>-0.2%</font>) and Juniper Networks (<a href=\"http://seekingalpha.com/symbol/JNPR\" target=\"_blank\">JNPR</a> <font color='red'>-1.6%</font>) with the <a href=\"http://ca.reuters.com/article/technologyNews/idCAKBN1952FG-OCATC\" target=\"_blank\">market's fastest routers</a>, an outgrowth of its multibillion-dollar acquisition of Alcatel-Lucent's IP Networking business.</li>    <li>The routers, based on the FP4 silicon, the world's fastest network chips, can handle heavier \"next-gen\" demands such as virtual reality and high-speed mobile, and are intended to help win business with \"Web-scale\" clients like Google, Facebook and Amazon.com.</li>    <li>A lot of those clients just want speed, ACG Research's Ray Mota tells Reuters. The new gear \"gives them an opportunity to approach the core network market with more credibility and gain some traction there.\"</li>    <li>Those new clients could offset flatness among Nokia's traditional telecom base as well.</li>    <li>The new products will ship in Q4.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273513\" data-linked=\"Nokia&#39;s fast routers pursue Web-scale customer base\" data-tweet=\"$NOK $NOK $CSCO - Nokia&#39;s fast routers pursue Web-scale customer base https://seekingalpha.com/news/3273513-nokias-fast-routers-pursue-web-scale-customer-base?source=tweet\" data-url=\"https://seekingalpha.com/news/3273513-nokias-fast-routers-pursue-web-scale-customer-base\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273509\" data-ts=\"1497464194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273509-treasurys-hang-on-to-big-gains-post-fomc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasurys hang on to big gains post-FOMC</a></h4><ul><li>As expected, the Fed boosted rates 25 basis points minutes ago. Even as the central bank cut its view for inflation this year to 1.7%, it continues to believe a return to 2% is in store for 2018.</li><li>The 10-year Treasury yield remains down 9 basis points to 2.12% (it was down about 10 bps prior to the rate decision). <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+1.75%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-3.5%</font></li><li><a href=\"https://www.federalreserve.gov/monetarypolicy/files/fomcprojtabl20170614.pdf\" target=\"_blank\">Growth projections remain </a>about the same.</li><li>The<a href=\"https://www.federalreserve.gov/monetarypolicy/files/fomcprojtabl20170614.pdf\" target=\"_blank\"> median projection of </a>the Fed Funds rate for year-end 2017 continues to be 1.4% (roughly one more rate hike), and for 2018, 2.1%. The projection for 2019 is trimmed to 2.9% from 3%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273506-fed-lifts-rates-25-basis-points-details-balance-sheet-unwinding-plan\" target=\"_blank\">Fed lifts rates by 25 basis points, details balance sheet unwinding plan</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273509\" data-linked=\"Treasurys hang on to big gains post-FOMC\" data-tweet=\"$TLT $TBT - Treasurys hang on to big gains post-FOMC https://seekingalpha.com/news/3273509-treasurys-hang-on-to-big-gains-post-fomc?source=tweet\" data-url=\"https://seekingalpha.com/news/3273509-treasurys-hang-on-to-big-gains-post-fomc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273508\" data-ts=\"1497463988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273508-mattel-volatile-after-lively-investor-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel volatile after lively investor day</a></h4><ul> <li><a href=\"https://seekingalpha.com/news/3272703-stocks-watch-next-week\" target=\"_blank\">As expected</a>, Mattel's (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) investor day was lively.</li> <li>The company slashed its quarterly dividend to $0.15 per share from $0.38 and lowered expectations for Q2 revenue growth.</li> <li>CEO Margo Georgiadis talked about the global pivot in the toy industry to mobile and digital. She noted 85% of children between the ages of three and five have access to a tablet. Mattel's strategy goals this year include building our Power Brands into \"360 connected\" systems of play and experiences, accelerating growth in emerging markets and transformating the innovation pipeline.</li><li>Mattel's CFO announced that no annual guidance would be forthcoming.</li><li>Shares of Mattel are&nbsp;<font color='red'>down 1.39%</font>&nbsp;after initially falling 5% when the dividend cut was tipped.</li><li><a href=\"http://edge.media-server.com/m/p/675f3gmu\" target=\"_blank\">Mattel investor day webcast</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3273508\" data-linked=\"Mattel volatile after lively investor day\" data-tweet=\"$MAT - Mattel volatile after lively investor day https://seekingalpha.com/news/3273508-mattel-volatile-after-lively-investor-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3273508-mattel-volatile-after-lively-investor-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273507\" data-ts=\"1497463879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273507-anadarko-petroleumminus-4-barclays-downgrades-to-underweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadarko Petroleum -4% as Barclays downgrades to Underweight</a></h4><ul><li>Anadarko Petroleum (<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color='red'>-4%</font>) is <a href=\"http://thefly.com/thestreet/realmoney/index.php/APCid2566118/APC-Anadarko-downgraded-to-Underweight-from-Equal-Weight-at-Barclays\" target=\"_blank\">downgraded</a> to Underweight from Equal Weight with a $42 price target, cut from $52, at Barclays, which believes low multiples are appropriate for APC's \"short-lived \" Gulf of Mexico assets and that E&amp;P investors should value  the MLP assets at less than market prices.</li><li>Barclays also thinks the stock has benefited too much from investor excitement about U.S.  light tight oil even though only roughly a third of Q1 oil volumes were from  the U.S. onshore.</li><li>Energy shares are broadly lower today as <a href=\"https://seekingalpha.com/news/3273473-crude-oil-falls-3_4-percent-fresh-ytd-lows-stockpiles-drop-less-expected\" target=\"_blank\">crude oil prices drop to YTD lows</a> following inventory data showing a smaller than expected draw.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273507\" data-linked=\"Anadarko Petroleum -4% as Barclays downgrades to Underweight\" data-tweet=\"$APC - Anadarko Petroleum -4% as Barclays downgrades to Underweight https://seekingalpha.com/news/3273507-anadarko-petroleumminus-4-barclays-downgrades-to-underweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3273507-anadarko-petroleumminus-4-barclays-downgrades-to-underweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273505\" data-ts=\"1497463248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273505-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FMSA' title='Fairmount Santrol, Inc.'>FMSA</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273505\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$HKRS $WLL $SM - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3273505-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3273505-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273502\" data-ts=\"1497461854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OUT\" target=\"_blank\">OUT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273502-outfront-media-in-94m-purchase-of-canadian-billboard-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outfront Media in $94M purchase of Canadian billboard assets</a></h4><ul>   <li>Outfront Media (NYSE:<a href='https://seekingalpha.com/symbol/OUT' title='Outfront Media, Inc.'>OUT</a>) is <font color='green'>up 1.6%</font> today after news that it's <a href=\"https://seekingalpha.com/pr/16861466-outfront-media-acquires-canadian-digital-billboard-portfolio\" target=\"_blank\">acquired a portfolio of Canadian billboards</a> belonging to Dynamic Outdoor.</li>    <li>The deal is structured as an equity purchase of certain subsidiaries of All Vision, which operates out-of-home advertising under the Dynamic Outdoor name.</li>    <li>Outfront is paying about $94.4M, $50M of that in cash and $44.4M in equity from its Canadian unit.</li>    <li>The digital billboards are spread across locations including Toronto, Montreal, Calgary, Edmonton and Vancouver.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273502\" data-linked=\"Outfront Media in $94M purchase of Canadian billboard assets\" data-tweet=\"$OUT - Outfront Media in $94M purchase of Canadian billboard assets https://seekingalpha.com/news/3273502-outfront-media-in-94m-purchase-of-canadian-billboard-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3273502-outfront-media-in-94m-purchase-of-canadian-billboard-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273498\" data-ts=\"1497461034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273498-rough-session-for-banks-rates-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for banks as rates plunge</a></h4><ul><li>Might the FOMC surprise with no rate hike this afternoon? <a href=\"https://seekingalpha.com/news/3273412-yields-drop-soft-retail-sales-cpi-numbers\" target=\"_blank\">There's a buying panic at the long end</a> of the Treasury curve, with the 10-year yield down 10 basis points to 2.115% - another low for the year, and a level not seen since the day after the U.S. election.</li><li>Meanwhile at the short end, <a href=\"https://seekingalpha.com/news/3273477-traders-slash-odds-rate-hikes-2017\" target=\"_blank\">traders are pricing in</a> only this afternoon's rate hike, and then nothing more for 2017.</li><li>There was some weak economic data this morning - retail sales had their worst month since Jan. 2016, and core CPI continues to fall - but it's hard to imagine this news causing a 10 basis point drop in the 10-year.</li><li>The major averages are flat, but the KBW Bank ETF (<a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> <font color='red'>-1.7%</font>) and KBW Regional Bank ETF (<a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> <font color='red'>-1.5%</font>) are both sharply lower - partly reversing a big run higher over the previous week.</li><li>Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-1.6%</font>), Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='red'>-1%</font>), JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-1.4%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='red'>-1.7%</font>), U.S. Bancorp (<a href='https://seekingalpha.com/symbol/USB' title='U.S. Bancorp'>USB</a> <font color='red'>-1.5%</font>), New York Community (<a href='https://seekingalpha.com/symbol/NYCB' title='New York Community Bancorp Inc.'>NYCB</a> <font color='red'>-2.3%</font>), PNC Financial (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='red'>-1.2%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a>, <a href='https://seekingalpha.com/symbol/FXO' title='First Trust Financials AlphaDEX ETF'>FXO</a>, <a href='https://seekingalpha.com/symbol/SEF' title='ProShares Short Financials ETF'>SEF</a>, <a href='https://seekingalpha.com/symbol/RYF' title='Invesco S&P Equal Weight Financial ETF'>RYF</a>, <a href='https://seekingalpha.com/symbol/FINU' title='ProShares UltraPro Financials ETF'>FINU</a>, <a href='https://seekingalpha.com/symbol/XLFS' title='Financial Services Select Sector SPDR ETF'>XLFS</a>, <a href='https://seekingalpha.com/symbol/FINZ' title='ProShares UltraPro Short Financials ETF'>FINZ</a>, <a href='https://seekingalpha.com/symbol/RWW' title='Oppenheimer Financials Sector Revenue ETF'>RWW</a>, <a href='https://seekingalpha.com/symbol/FAZZ' title='Direxion Daily Financial Bear 1x Shares ETF'>FAZZ</a>, <a href='https://seekingalpha.com/symbol/JHMF' title='John Hancock Multifactor Financials ETF'>JHMF</a>, <a href='https://seekingalpha.com/symbol/FNCF' title='iShares Edge MSCI Multifactor Financials ETF'>FNCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273498\" data-linked=\"Rough session for banks as rates plunge\" data-tweet=\"$BAC $KBE $KRE - Rough session for banks as rates plunge https://seekingalpha.com/news/3273498-rough-session-for-banks-rates-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/3273498-rough-session-for-banks-rates-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273493\" data-ts=\"1497458734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273493-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/WBKC' title='Wolverine Bancorp'>WBKC</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/OMNT' title='Ominto, Inc.'>OTCPK:OMNT</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/XCO' title='EXCO Resources, Inc.'>XCO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273493\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$EKSO $WBKC $OMNT - Midday Gainers / Losers https://seekingalpha.com/news/3273493-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3273493-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273487\" data-ts=\"1497456071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273487-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CRWS' title='Crown Crafts, Inc.'>CRWS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VRS' title='Verso Corporation'>VRS</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273487\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$REED $CRWS $NAKD - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3273487-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3273487-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273483\" data-ts=\"1497455326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273483-jefferies-e3-activision-ea-setting-up-for-strong-holidays\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies at E3: Activision, EA setting up for strong holidays</a></h4><ul>   <li>The first day of E3 has led to an <a href=\"http://www.investors.com/news/technology/click/these-two-video-game-publishers-well-positioned-for-holiday-sales\" target=\"_blank\">increase in confidence</a> at Jefferies in two videogame industry leaders: Activision Blizzard (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='green'>+1.2%</font>) and Electronic Arts (<a href=\"http://seekingalpha.com/symbol/EA\" target=\"_blank\">EA</a> <font color='green'>+0.6%</font>).</li>    <li>It's due in large part to shifting game slates: The two are \"well positioned\" for the holidays with some competition clearing out, including a <a href=\"https://seekingalpha.com/news/3269164-take-two-minus-9-percent-red-dead-redemption-2-delay\" target=\"_blank\">delay in <i>Red Dead Redemption 2</i></a> (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='green'>+1%</font>) to spring 2018 from a previously planned fall release.</li>    <li>That means key holiday games will be Activision's <i>Destiny 2</i> and <i>Call of Duty: WWII,</i> and EA's <i>Star Wars: Battlefront 2,</i> along with Ubisoft's (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='green'>+1.6%</font>) <i>Assassin's Creed Origins,</i> says Jefferies' Timothy O'Shea.</li>    <li>The new <i>Call of Duty</i> is drawing heavy attention at the show so far, along with the <i>Star Wars</i> sequel, says Piper Jaffray's Michael Olson.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273483\" data-linked=\"Jefferies at E3: Activision, EA setting up for strong holidays\" data-tweet=\"$ATVI $ATVI $EA - Jefferies at E3: Activision, EA setting up for strong holidays https://seekingalpha.com/news/3273483-jefferies-e3-activision-ea-setting-up-for-strong-holidays?source=tweet\" data-url=\"https://seekingalpha.com/news/3273483-jefferies-e3-activision-ea-setting-up-for-strong-holidays\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273480\" data-ts=\"1497454836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNM\" target=\"_blank\">ATNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273480-actiniums-webinar-on-lead-product-candidate-iomab-b-fails-to-excite-investors-shares-down-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Actinium&#39;s webinar on lead product candidate Iomab-B fails to excite investors; shares down 27% in a week</a></h4><ul><li>Actinium Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-18.7%</font>) continues the slide that began last week. Shares have lost&nbsp;<font color='red'>27%</font>&nbsp;of their value in four trading days. On Monday, the company hosted a webinar to update investors on lead product candidate, Orphan Drug-tagged <a href=\"http://www.actiniumpharma.com/product-pipeline/iomab-b\" target=\"_blank\">Iomab-B</a>, a radiotherapy used to prepare and condition leukemia patients for a bone marrow transplant.</li><li>It is currently being evaluated in a Phase 3 study called <a href=\"https://clinicaltrials.gov/ct2/show/NCT02665065?term=iomab-b&amp;rank=1\" target=\"_blank\">SIERRA</a>. The primary endpoint is durable complete remission lasting at least 180 days. According to ClinicalTrials.gov, the estimated final data collection date for the primary outcome measure is April 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273480\" data-linked=\"Actinium&#39;s webinar on lead product candidate Iomab-B fails to excite investors; shares down 27% in a week\" data-tweet=\"$ATNM - Actinium&#39;s webinar on lead product candidate Iomab-B fails to excite investors; shares down 27% in a week https://seekingalpha.com/news/3273480-actiniums-webinar-on-lead-product-candidate-iomab-b-fails-to-excite-investors-shares-down-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3273480-actiniums-webinar-on-lead-product-candidate-iomab-b-fails-to-excite-investors-shares-down-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273479\" data-ts=\"1497454296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPKKY\" target=\"_blank\">SPKKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273479-spark-new-zealand-nokia-team-on-network-upgrade-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spark New Zealand, Nokia team on network upgrade partnership</a></h4><ul>   <li>Spark New Zealand (<a href='https://seekingalpha.com/symbol/SPKKY' title='Spark New Zealand Limited ADR'>OTCPK:SPKKY</a> <font color='green'>+2%</font>, <a href='https://seekingalpha.com/symbol/NZTCF' title='Spark New Zealand Limited'>OTCPK:NZTCF</a> <font color='green'>+1.3%</font>) is using a <a href=\"https://seekingalpha.com/pr/16861102-spark-new-zealand-invests-strategic-partnership-nokia-core-infrastructure-prepare-5g-ultra\" target=\"_blank\">strategic partnership</a> with Nokia (<a href=\"http://seekingalpha.com/symbol/NOK\" target=\"_blank\">NOK</a> <font color='red'>-0.2%</font>) to revamp its core infrastructure ahead of anticipated growth tied to adoption of 5G technology and the Internet of Things.</li>    <li>It's a \"step change\" in the core and backhaul network, they say, and Spark says it's committed to keeping New Zealand among the forefront of 5G countries.</li>    <li>Nokia's IP/MPLS solutions are behind hundreds of networks worldwide, including Spark's broadband over wireless service.</li>    <li>The deal, set for three years, will exploit Nokia's 7250 Interconnect Router R6 (which features terabit capacity and high-port density and a wide range of interconnectivity options).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273479\" data-linked=\"Spark New Zealand, Nokia team on network upgrade partnership\" data-tweet=\"$SPKKY $SPKKY $NZTCF - Spark New Zealand, Nokia team on network upgrade partnership https://seekingalpha.com/news/3273479-spark-new-zealand-nokia-team-on-network-upgrade-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3273479-spark-new-zealand-nokia-team-on-network-upgrade-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273478\" data-ts=\"1497454050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273478-u-s-steelminus-4-analyst-warns-of-another-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel -4% as analyst warns of another guidance cut</a></h4><ul>     <li>U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-4.2%</font>) plunges after Axiom Capital analyst Gordon Johnson predicts the company will be forced to <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/06/9606745/gordon-johnson-warns-us-steel-likely-to-cut-guidance-aga\" target=\"_blank\">cut its EBITDA guidance again</a> when it reports later this summer.</li>     <li>Johnson says his \"proprietary X EBITDA guidance tracker analysis\" points to another ~28% cut; \"on average, using a 90% confidence interval, over four observations (2Q16-1Q17), our approach has predicted X&rsquo;s EBITDA within 96% of the guided number - X began guiding EBITDA this way in 4Q15.\"</li>     <li>Johnson, an establish bear on U.S. Steel, rates X as a Sell with downside to $14 by year-end.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273478\" data-linked=\"U.S. Steel -4% as analyst warns of another guidance cut\" data-tweet=\"$X - U.S. Steel -4% as analyst warns of another guidance cut https://seekingalpha.com/news/3273478-u-s-steelminus-4-analyst-warns-of-another-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3273478-u-s-steelminus-4-analyst-warns-of-another-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273473\" data-ts=\"1497453197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273473-crude-oil-falls-3_4-to-fresh-ytd-lows-stockpiles-drop-less-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil falls 3.4% to fresh YTD lows as stockpiles drop less than expected</a></h4><ul><li>U.S. crude oil tumbles to fresh lows, now <font color='red'>-3.4%</font> at $44.90/bbl, on the  heels of <a href=\"https://seekingalpha.com/news/3273456-eia-petroleum-inventories\" target=\"_blank\">EIA inventory data</a> which showed a smaller than expected draw   draw of 1.66M barrels vs. the consensus outlook for a much larger draw.</li><li><a href=\"https://seekingalpha.com/news/3273309-api-u-s-crude-supplies-rose-2_75m-barrels-last-week\" target=\"_blank\">Last night's API inventory data</a> showed a build of 2.753M barrels of oil for the week ending June 9, compared to the previous week's draw of  4.62M barrels.</li><li>Oil futures have taken out last week's lows and are now at the lowest levels since November 2016, and the energy sector (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-2.4%</font>) has slumped to the bottom of the S&amp;P.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/PXE' title='PowerShares Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Guggenheim S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='PowerShares Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273473\" data-linked=\"Crude oil falls 3.4% to fresh YTD lows as stockpiles drop less than expected\" data-tweet=\"$XLE $USO $OIL - Crude oil falls 3.4% to fresh YTD lows as stockpiles drop less than expected https://seekingalpha.com/news/3273473-crude-oil-falls-3_4-to-fresh-ytd-lows-stockpiles-drop-less-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3273473-crude-oil-falls-3_4-to-fresh-ytd-lows-stockpiles-drop-less-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273471\" data-ts=\"1497452842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTBC\" target=\"_blank\">MTBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273471-medical-transcription-up-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical Transcription up 21%</a></h4><ul><li>Medical Transcription Billing (<a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+20.8%</font>) is providing technical analysis aficionados a good example of positive action with its rebound off the daily chart's 50-day exponential moving average on a 4x spike in volume.</li><li>Shares jumped almost 10-fold from mid-April to mid-May on Q1 results-stoked buying. Revenues were up almost 61% and management expects robust long-term growth led by talkEHR, a voice-activated SaaS electronic health record system.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3265890-q1-beat-keeps-party-going-medical-transcription-billing-shares-seven-fold-less-three-weeks\" target=\"_blank\">Q1 beat keeps the party going in Medical Transcription Billing, shares up over seven-fold in less than three weeks</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273471\" data-linked=\"Medical Transcription up 21%\" data-tweet=\"$MTBC - Medical Transcription up 21% https://seekingalpha.com/news/3273471-medical-transcription-up-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3273471-medical-transcription-up-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273439\" data-ts=\"1497452743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273439-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals'>CRVS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273439\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$EKSO $NDRM $AEMD - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3273439-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3273439-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273468\" data-ts=\"1497452518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCP\" target=\"_blank\">HCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273468-hcp-up-2-after-two-notch-upgrade-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCP up 2% after two-notch upgrade at Raymond James</a></h4><ul><li>via Bloomberg's Lily Katz</li><li>Citing a better asset mix vs. peers, an attractive valuation, and a possible change in sentiment from remaining Brookdale Senior Living exposure, analyst Jonathan Hughes upgrades HCP (<a href='https://seekingalpha.com/symbol/HCP' title='HCP, Inc.'>HCP</a> <font color='green'>+2.2%</font>) to Outperform from Underperform.</li><li>His $35 price target suggests about&nbsp;<font color='green'>10% upside</font>&nbsp;from yesterday's close.</li><li>Under new leadership focused on returning HCP to its \"blue-chip status,\" the company has undergone a transformation over the past year, says Hughes: Removing exposure to skilled nursing with the QCP spin, and cutting exposure to Brookdale.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273468\" data-linked=\"HCP up 2% after two-notch upgrade at Raymond James\" data-tweet=\"$HCP $PEAK - HCP up 2% after two-notch upgrade at Raymond James https://seekingalpha.com/news/3273468-hcp-up-2-after-two-notch-upgrade-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3273468-hcp-up-2-after-two-notch-upgrade-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273466\" data-ts=\"1497452083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FVE\" target=\"_blank\">FVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273466-senior-living-names-higher-on-report-of-brookdale-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senior Living names higher on report of Brookdale deal</a></h4><ul><li>Brookdale Senior Living had been up double-digits, and is currently&nbsp;<font color='green'>higher by 7.3%</font>&nbsp;on a report it's near a sale to a Chinese investor for about $3B.</li><li>Rising alongside are Five Star Senior Living (<a href='https://seekingalpha.com/symbol/FVE' title='Five Star Senior Living, Inc.'>FVE</a> <font color='green'>+2.9%</font>) and Capital Senior Living (<a href='https://seekingalpha.com/symbol/CSU' title='Capital Senior Living Corporation'>CSU</a> <font color='green'>+4.3%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273410-china-investment-group-closing-brookdale-senior-living-shares-ahead-12-percent-premarket\" target=\"_blank\">China investment group closing in on Brookdale Senior Living; shares ahead 12% premarket</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273466\" data-linked=\"Senior Living names higher on report of Brookdale deal\" data-tweet=\"$FVE $FVE $CSU - Senior Living names higher on report of Brookdale deal https://seekingalpha.com/news/3273466-senior-living-names-higher-on-report-of-brookdale-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3273466-senior-living-names-higher-on-report-of-brookdale-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273457\" data-ts=\"1497450666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273457-ekso-bionics-shoots-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso Bionics shoots higher</a></h4><ul><li>Ekso Bionics (NASDAQ:<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a>) almost <font color='green'>triples in value</font> in early trade, with investors keeping an eye out to see if the upward trend will remain throughout the day.</li><li>The stock is still down heavily since the beginning of the year as shares <font color='red'>dropped almost 60%</font> from their $4 level in January.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273457\" data-linked=\"Ekso Bionics shoots higher\" data-tweet=\"$EKSO - Ekso Bionics shoots higher https://seekingalpha.com/news/3273457-ekso-bionics-shoots-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3273457-ekso-bionics-shoots-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273456\" data-ts=\"1497450651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273456-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>-1.7</strong><strong>M</strong> barrels vs. -2.7M consensus, +3.3M last week.</li><li>Gasoline <strong>+2.1M</strong> barrels vs. -0.5M consensus, +3.3M last week.</li><li>Distillates <strong>+0.3M</strong> vs. +0.7M consensus, +4.4M last week.</li><li>Futures&nbsp;<font color='red'>-1.57%</font>&nbsp;to $45.73.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3273456\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3273456-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3273456-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273455\" data-ts=\"1497450539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273455-squeeze-alert-on-hertz-global-and-avis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Squeeze alert on Hertz Global and Avis</a></h4><ul> <li>Hertz Global (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) is <font color='green'>up 6.14%</font> and Avis Budget Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a>) is <font color='green'>5.93% higher</font> as analyst commentary captures the attention of traders.</li> <li>Deutsche Bank is calling out the \"green shoots\" of positive investor sentiment that are emerging.</li> <li>Perhaps just as relevant, Notable Calls <a href=\"https://twitter.com/thenotablecalls/status/874984510458396672\" target=\"_blank\">reminds</a> that both car rental stocks are ripe for a short squeeze due to the high level of short interest outstanding.</li> <li>Yesterday, Avis and Hertz bounced after NADA revised its used car price data.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273211-hertz-avis-jump-corrected-nada-data\" target=\"_blank\">Hertz and Avis jump off of corrected NADA data</a> (June 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273455\" data-linked=\"Squeeze alert on Hertz Global and Avis\" data-tweet=\"$HTZ $HTZ $CAR - Squeeze alert on Hertz Global and Avis https://seekingalpha.com/news/3273455-squeeze-alert-on-hertz-global-and-avis?source=tweet\" data-url=\"https://seekingalpha.com/news/3273455-squeeze-alert-on-hertz-global-and-avis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273451\" data-ts=\"1497450322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VKTX\" target=\"_blank\">VKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273451-viking-announces-4_3m-direct-placement-of-stock-and-warrants-shares-down-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viking announces $4.3M direct placement of stock and warrants; shares down 8%</a></h4><ul><li>Thinly traded Viking Therapeutics (<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='red'>-7.9%</font>) slips on double normal volume in response to its <a href=\"https://seekingalpha.com/pr/16861850-viking-therapeutics-announces-4_3-million-registered-direct-offering\" target=\"_blank\">announcement </a>of a private of placement of stock and warrants with accredited investors.</li><li>Under the terms of the purchase agreement, the company will sell 3.7M shares of common stock and warrants to purchase up to 2.8M common shares for $1.15. The five-year warrants are exercisable at $1.30 per common share.</li><li>Closing date is June 19. Yesterday's close was $1.26.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273451\" data-linked=\"Viking announces $4.3M direct placement of stock and warrants; shares down 8%\" data-tweet=\"$VKTX - Viking announces $4.3M direct placement of stock and warrants; shares down 8% https://seekingalpha.com/news/3273451-viking-announces-4_3m-direct-placement-of-stock-and-warrants-shares-down-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3273451-viking-announces-4_3m-direct-placement-of-stock-and-warrants-shares-down-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273446\" data-ts=\"1497449270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HA\" target=\"_blank\">HA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273446-ual-move-weighs-on-hawaiian-holdings-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UAL move weighs on Hawaiian Holdings again</a></h4><ul> <li>Hawaiian Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a>) is <font color='red'>down another 10.02%</font> as analysts reset expectations following news that United Continental is adding flights into Hawaii.</li> <li>Stifel Nicolaus analyst Joseph DeNardi is the gloomiest of the bunch, downgrading Hawaiian Holdings to Sell and taking it price target down to a Street-low of $40.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273248-hawaiian-holdings-lower-ual-adds-flights-hawaii\" target=\"_blank\">Hawaiian Holdings lower after UAL adds flights to Hawaii</a> (June 13)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3273446\" data-linked=\"UAL move weighs on Hawaiian Holdings again\" data-tweet=\"$HA - UAL move weighs on Hawaiian Holdings again https://seekingalpha.com/news/3273446-ual-move-weighs-on-hawaiian-holdings-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3273446-ual-move-weighs-on-hawaiian-holdings-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273437\" data-ts=\"1497448199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIXI\" target=\"_blank\">ZIXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273437-imperial-capital-downgrades-zix-shares-up-2_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperial Capital downgrades Zix; shares up 2.4%</a></h4><ul><li>        Imperial <a href=\"https://www.benzinga.com/analyst-ratings/upgrades/17/06/9607059/benzingas-top-upgrades-downgrades-for-june-14-2017\" target=\"_blank\">downgrades</a> Zix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZIXI' title='Zix Corporation'>ZIXI</a>) from Outperform to In-Line.</li><li>               Latest analyst ratings: 1 Outperform, 2 Hold.&nbsp;</li><li>               Median price target: $6.&nbsp;</li><li>                  Zix shares are currently&nbsp;<font color='green'>up 2.38%</font>. &nbsp;   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3273437\" data-linked=\"Imperial Capital downgrades Zix; shares up 2.4%\" data-tweet=\"$ZIXI - Imperial Capital downgrades Zix; shares up 2.4% https://seekingalpha.com/news/3273437-imperial-capital-downgrades-zix-shares-up-2_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3273437-imperial-capital-downgrades-zix-shares-up-2_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273436\" data-ts=\"1497448123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273436-nordstrom-lower-after-cleveland-research-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom lower after Cleveland Research warning</a></h4><ul> <li>Shares of Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) are <font color='red'>down 0.90%</font> after Cleveland Research warns that Q2 comparable sales are tracking below consensus estimates.</li><li>Source: Bloomberg</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3273436\" data-linked=\"Nordstrom lower after Cleveland Research warning\" data-tweet=\"$JWN - Nordstrom lower after Cleveland Research warning https://seekingalpha.com/news/3273436-nordstrom-lower-after-cleveland-research-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3273436-nordstrom-lower-after-cleveland-research-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273435\" data-ts=\"1497448029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGR\" target=\"_blank\">RGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273435-gun-stocks-react-to-gop-baseball-team-shooting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gun stocks react to GOP baseball team shooting</a></h4><ul> <li>Sturm Ruger (NYSE:<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a>) is <font color='green'>up 1.79%</font> and American Outdoor Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a>) is <font color='green'>1.11% higher</font> after a shooting earlier this morning at a GOP House baseball team practice.</li> <li>The two stocks often react to shooting incidents as investors gauge potential implication on gun demand.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3273408-breaking-shooting-gop-house-baseball-practice\" target=\"_blank\">Shooting at GOP House baseball practice</a> (June 14)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3273435\" data-linked=\"Gun stocks react to GOP baseball team shooting\" data-tweet=\"$RGR $RGR $AOBC - Gun stocks react to GOP baseball team shooting https://seekingalpha.com/news/3273435-gun-stocks-react-to-gop-baseball-team-shooting?source=tweet\" data-url=\"https://seekingalpha.com/news/3273435-gun-stocks-react-to-gop-baseball-team-shooting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273428\" data-ts=\"1497446908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273428-infineraplus-7_7-mkm-upgrades-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera +7.7% as MKM upgrades to Buy</a></h4><ul>   <li>Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) is <font color='green'>up 7.7%</font> premarket after MKM Partners upgraded to Buy from Neutral.</li>    <li>Checks are providing confidence in Q2 numbers and suggest the company's largely past customer challenges of the past year, according to analyst Michael Genovese. In particular, spending from Level 3 -- the company's biggest customer with 16% of revenues -- is consistent.</li>    <li>The company does point-to-point as well as anyone, he suggests, and its new products fit that mold.</li>    <li>The firm boosted its price target to $14 from $10, implying 27.7% upside. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273428\" data-linked=\"Infinera +7.7% as MKM upgrades to Buy\" data-tweet=\"$INFN - Infinera +7.7% as MKM upgrades to Buy https://seekingalpha.com/news/3273428-infineraplus-7_7-mkm-upgrades-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3273428-infineraplus-7_7-mkm-upgrades-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273427\" data-ts=\"1497446836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273427-redhills-bekinda-successful-in-late-stage-gastroenteritis-study-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill&#39;s Bekinda successful in late-stage gastroenteritis study; shares ahead 7% premarket</a></h4><ul><li>Thinly traded micro cap Redhill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16861458-redhill-biopharma-announces-successful-phase-iii-top-line-results-bekinda-acute\" target=\"_blank\">announcement </a>of positive results from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02246439?term=rhb-102&amp;rank=1\" target=\"_blank\">GUARD</a>, assessing BEKINDA (RHB-102) for the treatment of acute gastroenteritis and gastritis.</li><li>The study met its primary endpoint of the proportion of patients without further vomiting, without rescue medication and who were not administered intravenous hydration from 30 minutes post-dose until 24 hours post-dose. 65.6% of the patients in the BEKINDA cohort met the efficacy criteria compared to 54.3% for placebo (p=0.04). The results for placebo were much higher than expected.</li><li>The company intends to review the data with the FDA and discuss a regulatory path to approval.</li><li>Management will host a conference call on Wednesday, June 21 at 8:00 am ET to discuss the data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273427\" data-linked=\"RedHill&#39;s Bekinda successful in late-stage gastroenteritis study; shares ahead 7% premarket\" data-tweet=\"$RDHL - RedHill&#39;s Bekinda successful in late-stage gastroenteritis study; shares ahead 7% premarket https://seekingalpha.com/news/3273427-redhills-bekinda-successful-in-late-stage-gastroenteritis-study-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3273427-redhills-bekinda-successful-in-late-stage-gastroenteritis-study-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273426\" data-ts=\"1497446709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQNS\" target=\"_blank\">SQNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273426-sequans-prices-share-offering-shares-down-2_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sequans prices share offering, shares down 2.5%</a></h4><ul><li>        IoT semiconductor company Sequans Communications (NYSE:<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a>) <a href=\"https://seekingalpha.com/pr/16861616-sequans-communications-s-announces-pricing-underwritten-public-offering-american-depositary\" target=\"_blank\">prices</a> the offering of American Depositary Shares announced yesterday.</li><li>               The price is $3.80 per ADS representing 3.75M ordinary shares with a 30pday option for an additional 562.5K to cover overallotments, if needed.&nbsp;</li><li>               Offering expected to close June 19.&nbsp;</li><li>               Sequans shares are&nbsp;<font color='red'>down 2.47%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273297-sequans-announces-american-depositary-shares-offering-shares-6-percent\" target=\"_blank\">Sequans announces American Depositary Shares offering; shares down 6%</a> (June 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273426\" data-linked=\"Sequans prices share offering, shares down 2.5%\" data-tweet=\"$SQNS - Sequans prices share offering, shares down 2.5% https://seekingalpha.com/news/3273426-sequans-prices-share-offering-shares-down-2_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3273426-sequans-prices-share-offering-shares-down-2_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273425\" data-ts=\"1497446511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273425-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+26%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16861291-mtbc-announces-launch-new-platform-support-continued-growth\" target=\"_blank\">announcement</a> of the initial launch of MTBC WebSoft.</li><li><a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3273391-microbot-medical-continues-solidify-ip-portfolio-us-patent-device-preventing-shunt-stenosis\" target=\"_blank\">continue</a> to solidify IP portfolio with US patent for device for preventing shunt stenosis.</li><li><a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a> <font color='green'>+10%</font>&nbsp;in <a href=\"https://seekingalpha.com/news/3273410-china-investment-group-closing-brookdale-senior-living-shares-ahead-12-percent-premarket\" target=\"_blank\">talks</a> with&nbsp;Zhonghong Zhuoye.</li><li><a href='https://seekingalpha.com/symbol/HRB' title='H&R Block Inc.'>HRB</a> <font color='green'>+9%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3273288-h-and-amp-r-block-beats-0_23-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color='green'>+9%.</font></li><li><a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='green'>+8%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/pr/16859982-infinera-unveils-xtm-ii-cloud-scale-metro-packet-optical-applications\" target=\"_blank\">launching</a>&nbsp;XTM II, a next generation packet-optical platform delivering rich Layer.</li><li><a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16861458-redhill-biopharma-announces-successful-phase-iii-top-line-results-bekinda-acute\" target=\"_blank\">announced</a> positive top-line results from the Phase III GUARD study with BEKINDA&nbsp;24 mg for acute gastroenteritis and gastritis.</li><li><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3261323-sorrento-closes-virttu-bio-buy\" target=\"_blank\">acquisition</a> of Glasgow.</li><li><a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3273360-genmark-diagnostics-prices-public-offering-common-stock\" target=\"_blank\">pricing</a>&nbsp;public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color='green'>+5%</font>.</li><li><a href='https://seekingalpha.com/symbol/DFIN' title='Donnelley Financial Solutions, Inc.'>DFIN</a> <font color='green'>+5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3273398-donnelley-financial-4-percent-pricing-secondary\" target=\"_blank\">pricing</a> secondary offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273425\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$MTBC $MBOT $BKD - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3273425-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3273425-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273423\" data-ts=\"1497446428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLDP\" target=\"_blank\">BLDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273423-ballard-power-wins-first-order-for-fuel-cell-system-to-power-commercial-uavs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ballard Power wins first order for fuel cell system to power commercial UAVs</a></h4><ul><li>Ballard Power (NASDAQ:<a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a>)&nbsp;<font color='green'>+1.8%</font> premarket on news that its Protonex subsidiary <a href=\"https://seekingalpha.com/pr/16861137-ballards-protonex-subsidiary-receives-first-order-fuel-cell-system-power-commercial-uavs\" target=\"_blank\">received an initial order</a> for its fuel cell propulsion system to power commercial UAVs.</li><li>The order is from FlyH2 Aerospace, a South African-based developer of hydrogen fuel  cell powered unmanned aerial vehicles for commercial applications; BLDP offers no commercial details of the order.</li><li>FlyH2 says it plans to integrate the BLDP fuel cell system into all three of  its aircraft currently in the development pipeline.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273423\" data-linked=\"Ballard Power wins first order for fuel cell system to power commercial UAVs\" data-tweet=\"$BLDP - Ballard Power wins first order for fuel cell system to power commercial UAVs https://seekingalpha.com/news/3273423-ballard-power-wins-first-order-for-fuel-cell-system-to-power-commercial-uavs?source=tweet\" data-url=\"https://seekingalpha.com/news/3273423-ballard-power-wins-first-order-for-fuel-cell-system-to-power-commercial-uavs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273421\" data-ts=\"1497446135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPZM\" target=\"_blank\">EPZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273421-interim-mid-stage-data-on-epizymes-tazemetostat-shows-lower-expected-response-rate-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interim mid-stage data on Epizyme&#39;s tazemetostat shows lower-than-expected response rate; shares down 17% premarket</a></h4><ul><li>Epizyme (NASDAQ:<a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a>) slumps&nbsp;<font color='red'>17%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16861575-epizyme-reports-positive-interim-data-phase-2-trial-tazemetostat-relapsed-refractory\" target=\"_blank\">announcement </a>of interim data from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT01897571?term=tazemetostat&amp;phase=1&amp;rank=4\" target=\"_blank\">Phase 2 clinical trial</a> assessing lead product candidate tazemetostat for the treatment of relapsed/refractory follicular lymphoma &#40;FL&#41; or diffuse large B-cell lymphoma &#40;DLBCL&#41;. The results were presented at the International Conference on Malignant Lymphoma in Lugano, Switzerland.</li><li>The overall response rate &#40;ORR&#41; in 17 DLBCL patients with a mutation called EZH2 was 29% which was lower than the 40% rate presented at ASCO on 10 patients, implying only one new responder out of seven (14%).</li><li><a href=\"http://www.epizyme.com/programs/tazemetostat/\" target=\"_blank\">Tazemetostat&nbsp;</a>inhibits an enzyme called&nbsp;<a href=\"https://en.wikipedia.org/wiki/EZH2\" target=\"_blank\">EZH2</a>&nbsp;(enhancer of zeste homolog 2), which plays a key role in DNA methylation and transcriptional repression. Mutation or over-expression of EZH2 is associated with a range of cancers.&nbsp;It is being developed for the treatment of non-Hodgkin lymphoma, certain genetically defined solid tumors and (until now) synovial sarcoma.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3227079-epizymes-tazemetostat-fast-trackd-dlbcl-development-monotherapy-synovial-sarcoma-axed-due\" target=\"_blank\">Epizyme's tazemetostat Fast Track'd for DLBCL; development as monotherapy in synovial sarcoma axed due to lack of effect</a> (Nov. 28, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273421\" data-linked=\"Interim mid-stage data on Epizyme&#39;s tazemetostat shows lower-than-expected response rate; shares down 17% premarket\" data-tweet=\"$EPZM - Interim mid-stage data on Epizyme&#39;s tazemetostat shows lower-than-expected response rate; shares down 17% premarket https://seekingalpha.com/news/3273421-interim-mid-stage-data-on-epizymes-tazemetostat-shows-lower-expected-response-rate-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3273421-interim-mid-stage-data-on-epizymes-tazemetostat-shows-lower-expected-response-rate-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273420\" data-ts=\"1497446006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273420-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a> <font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16861575-epizyme-reports-positive-interim-data-phase-2-trial-tazemetostat-relapsed-refractory\" target=\"_blank\">announcing</a>&nbsp;data from Phase 2 trial of Tazemetostat in relapsed or refractory Follicular Lymphoma and DLBCL patients.</li><li><a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3273373-aldeyras-lead-product-candidate-flunks-mid-stage-allergic-conjunctivitis-study-shares-19\" target=\"_blank\">announcing</a> ADX-102 failing to achieve primary endpoint in a&nbsp;Phase 2b clinical trial&nbsp;in allergic conjunctivitis.</li><li><a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3273420\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$EPZM $ALDX $MOSY - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3273420-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3273420-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273417\" data-ts=\"1497445252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QSR\" target=\"_blank\">QSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273417-oppenheimer-sees-upside-for-restaurant-brands-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer sees upside for Restaurant Brands International</a></h4><ul> <li>Oppenheimer upgrades Restaurant Brands International (NYSE:<a href='https://seekingalpha.com/symbol/QSR' title='Restaurant Brands International Inc.'>QSR</a>) to Outperform from Market Perform after factoring in the synergy benefits from the acquisition of Popeyes.</li>  <li>The firm notes that QSR trades at an \"oddly discounted\" free cash flow yield and price-to-earnings ratio.</li><li>Oppy's price target of $70 on the restaurant operator is a high from Wall Street firms.</li> <li>Source: Bloomberg</li><li>Shares of Restaurant Brands are <font color='green'>up 1.24%</font> premarket to $58.13.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273417\" data-linked=\"Oppenheimer sees upside for Restaurant Brands International\" data-tweet=\"$QSR - Oppenheimer sees upside for Restaurant Brands International https://seekingalpha.com/news/3273417-oppenheimer-sees-upside-for-restaurant-brands-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3273417-oppenheimer-sees-upside-for-restaurant-brands-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273413\" data-ts=\"1497445003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273413-precious-metals-tails-in-air-after-disappointing-economic-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Precious metals&#39; tails in the air after disappointing economic data</a></h4><ul><li>Retail sales in May turned in their worst month since January 2016, and core CPI rose only half as much as expected. The data <a href=\"https://seekingalpha.com/news/3273412-yields-drop-soft-retail-sales-cpi-numbers\" target=\"_blank\">has sent Treasury yields</a> and the dollar sharply lower.</li><li>Benefitting are the precious metals, with gold&nbsp;<font color='green'>jumping 0.5%</font>&nbsp;to $1,275 per ounce, and silver&nbsp;<font color='green'>1.65%</font>&nbsp;to $17.05. <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>&nbsp;<font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a>&nbsp;<font color='green'>+1.15%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3273413\" data-linked=\"Precious metals&#39; tails in the air after disappointing economic data\" data-tweet=\"$GLD $SLV - Precious metals&#39; tails in the air after disappointing economic data https://seekingalpha.com/news/3273413-precious-metals-tails-in-air-after-disappointing-economic-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3273413-precious-metals-tails-in-air-after-disappointing-economic-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273412\" data-ts=\"1497444563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273412-yields-drop-after-soft-retail-sales-and-cpi-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yields drop after soft retail sales and CPI numbers</a></h4><ul><li>Headline retail sales fell 0.3% in May vs. expectations for a small rise. It's the weakest print since January of 2016. Sales ex-autos and gas were flat vs.+0.3% expected.</li><li>Alongside, core CPI rose just 0.1% in May vs. +0.2% expected.</li><li>The 10-year Treasury yield is down six basis points to right around a 2017-low of 2.15% <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-1.4%</font></li><li>The dollar (<a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>, <a href='https://seekingalpha.com/symbol/UDN' title='PowerShares DB USD Bear ETF'>UDN</a>) has also turned solidly lower, with UUP&nbsp;<font color='red'>down 0.45%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273402-retail-sales-dip-may\" target=\"_blank\">Retail sales dip in May</a> (June 14)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3273399-consumer-price-index\" target=\"_blank\">Consumer Price Index</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3273412\" data-linked=\"Yields drop after soft retail sales and CPI numbers\" data-tweet=\"$TLT $TBT $UUP - Yields drop after soft retail sales and CPI numbers https://seekingalpha.com/news/3273412-yields-drop-after-soft-retail-sales-and-cpi-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3273412-yields-drop-after-soft-retail-sales-and-cpi-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273410\" data-ts=\"1497444404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKD\" target=\"_blank\">BKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273410-china-investment-group-closing-in-on-brookdale-senior-living-shares-ahead-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China investment group closing in on Brookdale Senior Living; shares ahead 12% premarket</a></h4><ul><li>Reuters <a href=\"https://www.reuters.com/article/us-brookdale-m-a-zhonghongzhuoyegroup-idUSKBN19425T\" target=\"_blank\">reports </a>that Chinese investor Zhonghong Zhuoye Group is in talks with Brookdale Senior Living (NYSE:<a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a>) to acquire the long-term care provider for ~$3B. Shares are up&nbsp;<font color='green'>12%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273410\" data-linked=\"China investment group closing in on Brookdale Senior Living; shares ahead 12% premarket\" data-tweet=\"$BKD - China investment group closing in on Brookdale Senior Living; shares ahead 12% premarket https://seekingalpha.com/news/3273410-china-investment-group-closing-in-on-brookdale-senior-living-shares-ahead-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3273410-china-investment-group-closing-in-on-brookdale-senior-living-shares-ahead-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273405\" data-ts=\"1497443940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273405-mabvax-pet-imaging-agent-mvtminus-2163-shows-robust-lesion-uptake-in-early-stage-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax PET imaging agent MVT-2163 shows robust lesion uptake in early-stage study; shares ahead 22% premarket</a></h4><ul><li>Thinly traded nano cap MabVax Therapeutics (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a>) is up&nbsp;<font color='green'>22%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16861341-mabvax-therapeutics-reports-positive-phase-1-results-mvtminus-2163-immunopet-imaging-agent\" target=\"_blank\">announcement</a> of positive results from a Phase 1 clinical trial assessing ImmunoPET imaging agent MVT-2163 in patients with locally advanced/metastatic adenocarcinoma of the pancreas or other CA19-9-positive malignancies (CA19-9 is a tumor biomarker produced by certain cancer cells). The results were presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Denver, CO.</li><li>MVT-2163 was administered alone or with MVT-5873 in 12 patients to assess MVT-2163's safety and ability to image pancreatic tumors or other CA19-9-positive cancers.</li><li>Uptake of MVT-2163 in primary tumors and metastases was observed as early as day 2 and continuously through day 7. A measurement of PET imaging activity called Standard Uptake Values &#40;SUV&#41; was as high as 101, among the highest lesion uptake values ever observed by investigators. Bone and soft tissue disease were clearly visible and lesion uptake of the radiotracer was higher than usually seen with PET imaging agents. Correlation with Computerized Tomography &#40;CT&#41; scans was high.</li><li>The only adverse events observed were infusion reactions that resolved the day of injection. Some required supportive medication.</li><li>The company says the high SUV values support the use of its radioimmunotherapy candidate MVT-1075 which uses the same antibody to deliver a dose of radiation to tumors. Patient dosing should commence by the end of the month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273405\" data-linked=\"MabVax PET imaging agent MVT-2163 shows robust lesion uptake in early-stage study; shares ahead 22% premarket\" data-tweet=\"$MBVX $MBVXQ - MabVax PET imaging agent MVT-2163 shows robust lesion uptake in early-stage study; shares ahead 22% premarket https://seekingalpha.com/news/3273405-mabvax-pet-imaging-agent-mvtminus-2163-shows-robust-lesion-uptake-in-early-stage-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3273405-mabvax-pet-imaging-agent-mvtminus-2163-shows-robust-lesion-uptake-in-early-stage-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273398\" data-ts=\"1497443422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRD\" target=\"_blank\">RRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273398-donnelley-financial-up-4-after-pricing-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Donnelley Financial up more than 4% after pricing secondary</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16861092-correcting-replacing-donnelley-financial-solutions-inc-announces-pricing-secondary-common\" target=\"_blank\">6.14M share sale</a> constituted R.R. Donnelley &amp; Sons' (NASDAQ:<a href='https://seekingalpha.com/symbol/RRD' title='R.R. Donnelley & Sons Company'>RRD</a>) remaining stake in Donnelley Financial Solutions (NYSE:<a href='https://seekingalpha.com/symbol/DFIN' title='Donnelley Financial Solutions, Inc.'>DFIN</a>). The offering priced at $21.25 per share.</li><li>The underwriters have a greenshoe option to buy another 921.5K shares at that price.</li><li>Donnelley Financial received no proceeds from the offering.</li><li>DFIN&nbsp;<font color='green'>+ 4.4%</font>&nbsp;premarket to $22.65.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273398\" data-linked=\"Donnelley Financial up more than 4% after pricing secondary\" data-tweet=\"$RRD $RRD $DFIN - Donnelley Financial up more than 4% after pricing secondary https://seekingalpha.com/news/3273398-donnelley-financial-up-4-after-pricing-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3273398-donnelley-financial-up-4-after-pricing-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273396\" data-ts=\"1497443102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOL\" target=\"_blank\">SOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273396-renesolaplus-8-after-ceo-proposes-to-acquire-parts-of-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReneSola +8% after CEO proposes to acquire parts of the company</a></h4><ul>     <li>ReneSola (NYSE:<a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a>) <font color='green'>+8.3%</font> premarket after announcing a non-binding <a href=\"https://seekingalpha.com/pr/16861255-renesola-announces-receipt-preliminary-non-binding-proposal-formation-special-committee\" target=\"_blank\">offer from Chairman and CEO Xianshou Li</a> to acquire the company's manufacturing and LED distribution businesses in exchange for the assumption of debt.</li><li>Li's proposal assumes assumption of debt of the acquired businesses, estimated at $81M, and SOL would issue additional ADS to Li at $4.50/share.</li><li>If the deal is completed, SOL's remaining businesses would focus primarily on solar  project development.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3273396\" data-linked=\"ReneSola +8% after CEO proposes to acquire parts of the company\" data-tweet=\"$SOL - ReneSola +8% after CEO proposes to acquire parts of the company https://seekingalpha.com/news/3273396-renesolaplus-8-after-ceo-proposes-to-acquire-parts-of-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3273396-renesolaplus-8-after-ceo-proposes-to-acquire-parts-of-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273391\" data-ts=\"1497442685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273391-microbot-medical-continues-to-solidify-ip-portfolio-us-patent-for-device-for-preventing-shunt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microbot Medical continues to solidify IP portfolio with US patent for device for preventing shunt stenosis; shares are ahead 12% premarket</a></h4><ul> <li>Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) <a href=\"https://seekingalpha.com/pr/16861335-microbot-medical-inc-continues-solidify-ip-portfolio-us-patent-previously-disclosed-device\" target=\"_blank\">announces</a> that the United States Patent and Trademark Office has issued a patent covering a device for the prevention of shunt stenosis.</li><li>Specifically, the patent covers systems and methods for reducing venous stenosis associated with the use of hemodialysis shunts, providing an additional layer of protection to Microbot's&nbsp;<a href=\"http://www.microbotmedical.com/technology/tipcat/\" target=\"_blank\">TipCat</a>&nbsp;and&nbsp;<a href=\"http://www.microbotmedical.com/technology/virob/\" target=\"_blank\">ViRob</a>&nbsp;platforms.</li><li>The Company also filed a Continuation Application to further establish and enhance the Company&rsquo;s solutions for preventing shunt stenosis.</li>     <li>Shares are up&nbsp;<font color='green'>12%</font>&nbsp;premarket on average volume.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3273391\" data-linked=\"Microbot Medical continues to solidify IP portfolio with US patent for device for preventing shunt stenosis; shares are ahead 12% premarket\" data-tweet=\"$MBOT - Microbot Medical continues to solidify IP portfolio with US patent for device for preventing shunt stenosis; shares are ahead 12% premarket https://seekingalpha.com/news/3273391-microbot-medical-continues-to-solidify-ip-portfolio-us-patent-for-device-for-preventing-shunt?source=tweet\" data-url=\"https://seekingalpha.com/news/3273391-microbot-medical-continues-to-solidify-ip-portfolio-us-patent-for-device-for-preventing-shunt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273374\" data-ts=\"1497440795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBNC\" target=\"_blank\">HBNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273374-midwest-bank-m-horizon-buying-wolverine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midwest bank M&amp;A: Horizon buying Wolverine</a></h4><ul><li>Michigan City, Indiana-based Horizon Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/HBNC' title='Horizon Bancorp &#40;IN&#41;'>HBNC</a>) agrees to buy Midland, Michigan-based Wolverine Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/WBKC' title='Wolverine Bancorp'>WBKC</a>) in a stock and cash deal currently valued at $41.92 per WBKC share - a&nbsp;<font color='green'>34% premium</font>&nbsp;to last night's close.</li><li>The deal is expected to close late in Q3, or early in Q4.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16861357-horizon-bancorp-wolverine-bancorp-sign-merger-agreement\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3273374\" data-linked=\"Midwest bank M&amp;A: Horizon buying Wolverine\" data-tweet=\"$HBNC $HBNC $WBKC - Midwest bank M&amp;A: Horizon buying Wolverine https://seekingalpha.com/news/3273374-midwest-bank-m-horizon-buying-wolverine?source=tweet\" data-url=\"https://seekingalpha.com/news/3273374-midwest-bank-m-horizon-buying-wolverine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273373\" data-ts=\"1497440684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273373-aldeyras-lead-product-candidate-flunks-mid-stage-allergic-conjunctivitis-study-shares-down-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aldeyra&#39;s lead product candidate flunks mid-stage allergic conjunctivitis study; shares down 19% premarket</a></h4><ul><li>Thinly traded nano cap Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) slumps&nbsp;<font color='red'>19%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16861270-aldeyra-therapeutics-announces-results-allergic-conjunctivitis-phase-2b-clinical-trial-plans\" target=\"_blank\">announcement</a> that lead product candidate, eye drop ADX-102, failed to achieve the primary endpoint in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03012165?term=adx-102&amp;rank=2\" target=\"_blank\">Phase 2b clinical trial</a> in allergic conjunctivitis.</li><li>The 154-subject study failed to demonstrate that treatment with either of two strengths of ADX-102 (0.5%, 0.1%) produced at least a one point improvement in an ocular itching scale compared to vehicle (placebo).</li><li>The company says the 0.5% strength showed statistically significant efficacy compared to vehicle in reducing ocular itching over one hour post-challenge, specifically at time points 10, 20 and 30 minutes post challenge. It plans to advance this formulation into Phase 3 development.</li><li>Management will host a conference call this morning at 8:00 am ET to discuss the results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3273373\" data-linked=\"Aldeyra&#39;s lead product candidate flunks mid-stage allergic conjunctivitis study; shares down 19% premarket\" data-tweet=\"$ALDX - Aldeyra&#39;s lead product candidate flunks mid-stage allergic conjunctivitis study; shares down 19% premarket https://seekingalpha.com/news/3273373-aldeyras-lead-product-candidate-flunks-mid-stage-allergic-conjunctivitis-study-shares-down-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3273373-aldeyras-lead-product-candidate-flunks-mid-stage-allergic-conjunctivitis-study-shares-down-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273371\" data-ts=\"1497440605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOS\" target=\"_blank\">GOOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273371-canada-goose-to-sell-subordinate-voting-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada Goose to sell subordinate voting shares</a></h4><ul> <li>Canada Goose (NYSE:<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a>) files to sell $322M worth of subordinate voting shares for holders.</li> <li>The company says it won't receive any of the proceeds from the sale of shares.</li> <li><a href=\"https://seekingalpha.com/filing/3593401\" target=\"_blank\">SEC Form F-1</a></li><li>GOOS&nbsp;<font color='green'>+0.22%</font>&nbsp;premarket to $22.45.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3273371\" data-linked=\"Canada Goose to sell subordinate voting shares\" data-tweet=\"$GOOS - Canada Goose to sell subordinate voting shares https://seekingalpha.com/news/3273371-canada-goose-to-sell-subordinate-voting-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3273371-canada-goose-to-sell-subordinate-voting-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273369\" data-ts=\"1497440224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273369-wedbush-cautious-on-starbucks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush cautious on Starbucks</a></h4><ul> <li>Wedbush lowers Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) to a Neutral rating from Outperform after channel checks indicate the chain's comparable sales are running \"in-line\" with Q2 estimates at best.</li> <li>The firm notes that the double-digit rally in SBUX over the last three months is based off of high expectation for the Q2 comp.</li> <li>Shares of Starbucks are <font color='red'>down 0.85%</font> in premarket trading to $60.40 vs. a 52-week trading range of $50.84 to $64.87.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3273369\" data-linked=\"Wedbush cautious on Starbucks\" data-tweet=\"$SBUX - Wedbush cautious on Starbucks https://seekingalpha.com/news/3273369-wedbush-cautious-on-starbucks?source=tweet\" data-url=\"https://seekingalpha.com/news/3273369-wedbush-cautious-on-starbucks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3273360\" data-ts=\"1497439247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNMK\" target=\"_blank\">GNMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3273360-genmark-diagnostics-prices-public-offering-of-common-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GenMark Diagnostics prices public offering of common stock</a></h4><ul> <li>GenMark Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a>) <a href=\"https://seekingalpha.com/pr/16861108-genmark-diagnostics-prices-upsized-public-offering-common-stock\" target=\"_blank\">announces</a> the pricing of its upsized underwritten public offering of 6.4M shares of its common stock at       a price of $11.75 per share. Gross proceeds will now be ~$75M, up from $65M.</li><li>Closing date is June 19.</li><li>Net proceeds from the offering will be used for general corporate purposes and to fund its commercialization efforts.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li>                         </ul><div class=\"tiny-share-widget\" data-id=\"3273360\" data-linked=\"GenMark Diagnostics prices public offering of common stock\" data-tweet=\"$GNMK - GenMark Diagnostics prices public offering of common stock https://seekingalpha.com/news/3273360-genmark-diagnostics-prices-public-offering-of-common-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3273360-genmark-diagnostics-prices-public-offering-of-common-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM </div></div></li>","count":69,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}